KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,326 | -43.1% | 1,510 | -27.1% | 0.01% | -46.7% |
| Q2 2023 | $449,096 | +127484.1% | 2,071 | +6.8% | 0.02% | +36.4% |
| Q1 2023 | $352 | +40.8% | 1,940 | +52.5% | 0.01% | +10.0% |
| Q4 2022 | $250 | -100.0% | 1,272 | -84.2% | 0.01% | -65.5% |
| Q3 2022 | $1,805,000 | +373.8% | 8,027 | +166.8% | 0.03% | +222.2% |
| Q2 2022 | $381,000 | +277.2% | 3,009 | +277.5% | 0.01% | +800.0% |
| Q1 2022 | $101,000 | -74.7% | 797 | -73.9% | 0.00% | -85.7% |
| Q4 2021 | $399,000 | +114.5% | 3,049 | +100.7% | 0.01% | +40.0% |
| Q3 2021 | $186,000 | -42.6% | 1,519 | -46.6% | 0.01% | -37.5% |
| Q2 2021 | $324,000 | +256.0% | 2,842 | +276.9% | 0.01% | +300.0% |
| Q1 2021 | $91,000 | -35.9% | 754 | -46.0% | 0.00% | -50.0% |
| Q4 2020 | $142,000 | +111.9% | 1,397 | +60.6% | 0.00% | +300.0% |
| Q3 2020 | $67,000 | -88.3% | 870 | -83.1% | 0.00% | -95.8% |
| Q2 2020 | $575,000 | – | 5,155 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |